← Leaderboards
Jay L Degen
Children'S Hospital Med Ctr (Cincinnati)
$9,965,421
Attributed
$11,844,127
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$11,844,127 · 11
By mechanism
R01$10,066,846 · 8
U01$1,757,281 · 1
R13$20,000 · 2
Top collaborators
- Punam Malik4 shared
- Charles T Quinn1 shared
- Jeffrey A Towbin1 shared
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Joseph S Palumbo$7,479,206
Others in their field
Top investigators on “Fibrinogen”
- Joel S. Bennett · University Of Pennsylvania$26,814,222
- Sanford J Shattil · Scripps Research Institute$14,225,021
- Barry Coller · Rockefeller University$13,964,791
- Satya P. Kunapuli · Temple University$12,979,321
- Margaret Rita Karagas · Dartmouth College$12,477,616
- Juliette Madan · Dartmouth College$11,448,845
Research focus
FibrinogenIntegrinsGene TargetingMutantPlasminogenReceptorIn VivoMediatingInflammatoryProgramsLaboratory MouseFibrinProteolysisPharmacia Brand Of EstropipateHemostatic AgentsInflammationDisease /Disorder ModelProthrombinThrombinNovel TherapeuticsProtein CResearch PersonnelBlood Coagulation FactorPlasminogen Activator
Grant awards (31)
Cincinnati Center of Excellence in Hemoglobinopathies Research$1,757,281
U01 · FY2015 · HL
Hemostatic factors and sickle cell disease$374,850
R01 · FY2014 · HL · contact PI
Hemostatic factors and sickle cell disease$364,140
R01 · FY2013 · HL · contact PI
Hemostatic factors and sickle cell disease$382,500
R01 · FY2012 · HL · contact PI
Thrombin-mediated proteolysis in neuroinflammatory disease$371,250
R01 · FY2012 · HL · contact PI
Thrombin-mediated proteolysis in neuroinflammatory disease$375,000
R01 · FY2011 · HL · contact PI
FASEB SRC on Protease in Hemostasis and Vascular Biology$10,000
R13 · FY2011 · HL · contact PI
Thrombin-mediated proteolysis in neuroinflammatory disease$375,000
R01 · FY2010 · HL · contact PI
Hemostatic Factors as Determinants of Bacterial Virulence and Host Defense.$364,125
R01 · FY2010 · HL · contact PI
Thrombin-mediated proteolysis in neuroinflammatory disease$375,000
R01 · FY2009 · HL · contact PI
Hemostatic Factors as Determinants of Bacterial Virulence and Host Defense$364,125
R01 · FY2009 · HL · contact PI
Hemostatic Factors as Determinants of Bacterial Virulence and Host Defense$364,125
R01 · FY2008 · HL · contact PI
Arthritic Disease and the Hemostatic System$314,980
R01 · FY2008 · AR · contact PI
Hemostatic Factors as Determinants of Bacterial Virulence and Host Defense$364,125
R01 · FY2007 · HL · contact PI
Arthritic Disease and the Hemostatic System$321,409
R01 · FY2007 · AR · contact PI
Hemostatic Factors as Determinants of Bacterial Virulence and Host Defense.$375,000
R01 · FY2006 · HL · contact PI
Arthritic Disease and the Hemostatic System$331,009
R01 · FY2006 · AR · contact PI
Mechanisms linking hemostatic factors and malignancy$444,642
R01 · FY2005 · HL
Characterization and use of prothrombin deficient mice$370,000
R01 · FY2005 · HL
Arthritic Disease and the Hemostatic System$338,975
R01 · FY2005 · AR
Mechanisms linking hemostatic factors and malignancy$431,691
R01 · FY2004 · HL
Characterization and use of prothrombin deficient mice$370,000
R01 · FY2004 · HL
Arthritic Disease and the Hemostatic System$338,975
R01 · FY2004 · AR
Mechanisms linking hemostatic factors and malignancy$358,265
R01 · FY2003 · HL
HEMOSTATIC FACTORS AND THE INFLAMMATORY RESPONSE$372,543
R01 · FY2002 · HL
Mechanisms linking hemostatic factors and malignancy$347,828
R01 · FY2002 · HL
7th Gordon Research Conference on Thrombolysis$10,000
R13 · FY2002 · HL
HEMOSTATIC FACTORS AND THE INFLAMMATORY RESPONSE$361,692
R01 · FY2001 · HL
HEMOSTATIC FACTORS IN VASCULAR DISEASE$286,392
R01 · FY2001 · HL
HEMOSTATIC FACTORS AND THE INFLAMMATORY RESPONSE$351,154
R01 · FY2000 · HL
HEMOSTATIC FACTORS IN VASCULAR DISEASE$278,051
R01 · FY2000 · HL